Search - tctmd.com

Displaying 1 - 20 of 67

Sort: Relevancy | Date

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

News Daily News

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Michael O'Riordan

April 22, 2025

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Daily News

No Spike in Cardiac Arrests, Deaths in Young Athletes During COVID-19

Todd Neale

February 26, 2025

News Daily News

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Yael L. Maxwell

February 20, 2025

News Daily News

Aspirin Use for Primary Prevention Declining in US: NHANES

Michael O'Riordan

January 24, 2025

News Daily News

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Michael O'Riordan

November 13, 2024

News Daily News

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

Michael O'Riordan

November 07, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Daily News

Good News for CV Recovery After COVID-19 Vaccine Myocarditis

Yael L. Maxwell

August 29, 2024

News Daily News

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Yael L. Maxwell

August 16, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Yael L. Maxwell

July 10, 2024

News Daily News

Data Fail to Support Link Between COVID-19 Vaccines and SCD in Young People

Todd Neale

April 19, 2024

News Daily News

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

Michael O'Riordan

March 20, 2024

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Daily News

Experts Warn of Looming Private Equity Interest in Cardiology Care

Michael O'Riordan

January 15, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Daily News

Who Benefits Most From Semaglutide and How Long Will That Take?

Shelley Wood

December 19, 2023

News Daily News

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

Todd Neale

December 12, 2023

Advertisement

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

No Spike in Cardiac Arrests, Deaths in Young Athletes During COVID-19

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Aspirin Use for Primary Prevention Declining in US: NHANES

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Good News for CV Recovery After COVID-19 Vaccine Myocarditis

CMS Announces Negotiated Medicare Prices for First 10 Drugs

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Real-world Patients Might Lose More Weight With Tirzepatide vs Semaglutide

Data Fail to Support Link Between COVID-19 Vaccines and SCD in Young People

FDA Approves Aprocitentan for Inadequately Controlled Hypertension

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Experts Warn of Looming Private Equity Interest in Cardiology Care

Top Endovascular News of 2023

Who Benefits Most From Semaglutide and How Long Will That Take?

Stopping Tirzepatide Leads to Rebound in Weight, Cardiometabolic Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content